Intracranial Arteriosclerosis clinical trials at UCSD
1 research study open to eligible people
Showing trials for
Comparison of Anti-coagulation and Anti-Platelet Therapies for Intracranial Vascular Atherostenosis
open to eligible people ages 30-80
The primary goal of the trial is to determine if the experimental arms (rivaroxaban or ticagrelor or both) are superior to the clopidogrel arm for lowering the 1-year rate of ischemic stroke, intracerebral hemorrhage, or vascular death.
La Jolla, California and other locations
Our lead scientists for Intracranial Arteriosclerosis research studies include Dawn Meyer.
Last updated: